Yayınlar & Eserler

Yayın Ağı
Makaleler 10
Tümü (10)
SCI-E, SSCI, AHCI (9)
SCI-E, SSCI, AHCI, ESCI (10)
Scopus (10)
TRDizin (3)

1. Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis

Güzel H. G., KIVRAK SALİM D., Kılıçkap S., Kemal Y., Akosman C., Köseoğlu Ç., et al.
Oncologist , cilt.31, sa.4, 2026 (SCI-Expanded, Scopus)

2. Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group

Şahin G., Tüzün E. K., Güzel H. G., Guliyev M., Dişli A. K., YAZICI M., et al.
International Journal of Cancer , cilt.158, sa.4, ss.1067-1079, 2026 (SCI-Expanded, Scopus)

3. Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG)

On S., Cebeci S., Turna Z. H., Güç Sevgen Z. G., GÜVEN D. C., Kılıçkap S., et al.
Cancers , cilt.18, sa.3, 2026 (SCI-Expanded, Scopus)

4. Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study

Yildirim H. C., Kapar C., Koksal B., Seyyar M., Sanci P. C., Guliyev M., et al.
Journal of Chemotherapy , cilt.37, sa.1, ss.69-75, 2025 (SCI-Expanded, Scopus)

5. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Taşçı E. Ş., Oyan B., Sönmez Ö., Mutlu A. U., Atcı M. M., Sakin A., et al.
BMC Cancer , cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)

6. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

Karacin C., Oksuzoglu B., Demirci A., Keskinkılıç M., Baytemür N. K., Yılmaz F., et al.
BMC Cancer , cilt.23, sa.1, 2023 (SCI-Expanded, Scopus)

7. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study

ÖZDEMİR Ö., Zengel B., Yildiz Y., Uluç B. O., ÇABUK D., Ozden E., et al.
Anti-Cancer Drugs , cilt.33, sa.7, ss.663-670, 2022 (SCI-Expanded, Scopus)

8. Outcomes and clinical features of leptomeningeal carcinomatosis: A single center experience

KIVRAK SALİM D., Onder A. H.
Marmara Medical Journal , cilt.32, sa.2, ss.81-85, 2019 (Scopus, TRDizin) Creative Commons License

9. Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals

KIVRAK SALİM D., Bayram S., Gömceli I., ÇEKİN A. H., Karaca M., KOÇER M., et al.
Turkish Journal of Gastroenterology , cilt.30, sa.10, ss.910-916, 2019 (SCI-Expanded, Scopus, TRDizin)

10. Comparison of three first-line treatments in advanced pancreatic cancer patients older than 65 years of age: Single-centre experience Altmiş beş yaş ve üzeri metastatik pankreas kanseri hastalarinda birinci sira üç farkli tedavinin karşilaştirilmasi: Tek merkez deneyimi

KIVRAK SALİM D., YILDIZ M.
Turk Geriatri Dergisi , cilt.22, sa.4, ss.384-390, 2019 (SCI-Expanded, SSCI, Scopus, TRDizin)
Metrikler

Yayın

10

Yayın (WoS)

10

Yayın (Scopus)

10

H-İndeks (WoS)

4

Atıf (Scopus)

42

H-İndeks (Scopus)

4

Proje

1

Tez Danışmanlığı

2

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER